IRIDEX CORP (IRIX) Stock Price, Quote, News and Overview
NASDAQ:IRIX - Nasdaq - US4626841013 - Common Stock - Currency: USD
IRIX Quote, Performance and Key Statistics
NASDAQ:IRIX (5/28/2025, 8:00:02 PM)
0.948
+0.01 (+0.53%)
The current stock price of IRIX is 0.948 USD. In the past month the price decreased by -19.66%. In the past year, price decreased by -60.99%.
IRIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.62 | 229.69B | ||
| ISRG | INTUITIVE SURGICAL INC | 72.3 | 197.99B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.71 | 154.62B | ||
| SYK | STRYKER CORP | 30.36 | 145.37B | ||
| MDT | MEDTRONIC PLC | 14.77 | 104.19B | ||
| BDX | BECTON DICKINSON AND CO | 12.28 | 49.59B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.48 | 44.97B | ||
| IDXX | IDEXX LABORATORIES INC | 45.12 | 41.68B | ||
| RMD | RESMED INC | 26.96 | 35.89B | ||
| DXCM | DEXCOM INC | 52.72 | 34.11B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.47 | 32.58B | ||
| STE | STERIS PLC | 26.23 | 24.07B |
Related stock screener links
About IRIX
Company Profile
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The company develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Company Info
IRIDEX CORP
1212 Terra Bella Ave
Mountain View CALIFORNIA 94043 US
CEO: David I. Bruce
Employees: 93
Phone: 16509404700
IRIDEX CORP / IRIX FAQ
What is the stock price of IRIDEX CORP today?
The current stock price of IRIX is 0.948 USD. The price increased by 0.53% in the last trading session.
What is the ticker symbol for IRIDEX CORP stock?
The exchange symbol of IRIDEX CORP is IRIX and it is listed on the Nasdaq exchange.
On which exchange is IRIX stock listed?
IRIX stock is listed on the Nasdaq exchange.
What is IRIDEX CORP worth?
IRIDEX CORP (IRIX) has a market capitalization of 15.92M USD. This makes IRIX a Nano Cap stock.
How many employees does IRIDEX CORP have?
IRIDEX CORP (IRIX) currently has 93 employees.
What are the support and resistance levels for IRIDEX CORP (IRIX) stock?
IRIDEX CORP (IRIX) has a support level at 0.94 and a resistance level at 1.02. Check the full technical report for a detailed analysis of IRIX support and resistance levels.
Is IRIDEX CORP (IRIX) expected to grow?
The Revenue of IRIDEX CORP (IRIX) is expected to grow by 5.44% in the next year. Check the estimates tab for more information on the IRIX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy IRIDEX CORP (IRIX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IRIX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IRIX, evaluating the profitability, health, valuation and growth aspects
- IRIDEX CORP (IRIX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IRIDEX CORP (IRIX) Sales and EPS estimates to see what analysts future expectations are.
- IRIDEX CORP (IRIX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IRIDEX CORP (IRIX) Insider and Institutional Ownership to learn about the owners and their transactions.
- IRIDEX CORP (IRIX) Stock Chart to make your own analysis
- IRIDEX CORP (IRIX) Latest news and press-releases to stay up to date.
Does IRIDEX CORP (IRIX) stock pay dividends?
IRIX does not pay a dividend.
When does IRIDEX CORP (IRIX) report earnings?
IRIDEX CORP (IRIX) will report earnings on 2025-08-06, after the market close.
What is the Price/Earnings (PE) ratio of IRIDEX CORP (IRIX)?
IRIDEX CORP (IRIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.43).
What is the Short Interest ratio of IRIDEX CORP (IRIX) stock?
The outstanding short interest for IRIDEX CORP (IRIX) is 2.14% of its float. Check the ownership tab for more information on the IRIX short interest.
IRIX Technical Analysis
IRIX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IRIX. IRIX has a bad profitability rating. Also its financial health evaluation is rather negative.
IRIX Financial Highlights
Over the last trailing twelve months IRIX reported a non-GAAP Earnings per Share(EPS) of -0.43. The EPS increased by 35.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.83% | ||
| ROE | -104.09% | ||
| Debt/Equity | 0.53 |
IRIX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to IRIX. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 49% and a revenue growth 5.44% for IRIX